In hepatocellular carcinoma, overexpression of miR-760 downregulates the expression of Notch1 and Hes1, increasing the sensitivity of tumor cells to the chemotherapeutic drug doxorubicin (131). Here, HES1 is linked to hepatocellular carcinoma.